Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ACH-ANASTROZOLE 1 MG — DIN 02351218

ANASTROZOLE : 1 MG · ACCORD HEALTHCARE INC · TABLET · wholesale supply in Canada

Health Canada status: MARKETED

What is ACH-ANASTROZOLE?

ACH-ANASTROZOLE 1 MG contains ANASTROZOLE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02351218, held by ACCORD HEALTHCARE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 23-Oct-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

How much does Anastrozole cost around the world?

Anastrozole is listed on 13 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Statesacquisition121USD███.██
Czechiamax producer price (ex-factory)917CZK███.██
AustriaKVP (Kassenverkaufspreis)1212EUR███.██
South Africasingle exit price1212ZAR███.██
Australiaex-manufacturer510AUD███.██
Hungaryproducer price (ex-factory)79HUF███.██
Saudi Arabiapublic77SAR███.██
Greeceproducer price (ex-factory)55EUR███.██
Luxembourgreimbursement33EUR███.██
MoroccoPPV (public price)23MAD███.██
United Arab Emiratespublic22AED███.██
Bahrainretail (max)22BHD███.██
United Kingdomhospital11GBP███.██

104 pack listings across 68 brand entries and 11 price bases, refreshed 08 Sep 2026. Ranges span every Anastrozole pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Anastrozole in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

26 holders have a Canadian DIN containing Anastrozole, across 30 DINs, of which 18 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
JAMP PHARMA CORPORATION22JAMP ANASTROZOLE TABLETS, JAMP-ANASTROZOLESourceable in Canada
ANGITA PHARMA INC.21AG-ANASTROZOLE, AG-ANASTROZOLE TABLETSSourceable in Canada
MARCAN PHARMACEUTICALS INC21IPG-ANASTROZOLE, MAR-ANASTROZOLESourceable in Canada
TEVA CANADA LIMITED21TEVA-ANASTROZOLESourceable in Canada
ACCORD HEALTHCARE INC11ACH-ANASTROZOLESourceable in Canada
APOTEX INC11APO-ANASTROZOLESourceable in Canada
ASTRAZENECA CANADA INC11ARIMIDEXSourceable in Canada
BIOMED PHARMA11BIO-ANASTROZOLESourceable in Canada
LABORATOIRE RIVA INC.11RIVA-ANASTROZOLESourceable in Canada
MINT PHARMACEUTICALS INC11MINT-ANASTROZOLESourceable in Canada
NATCO PHARMA (CANADA) INC11NAT-ANASTROZOLESourceable in Canada
PHARMASCIENCE INC11PMS-ANASTROZOLESourceable in Canada

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label1 MG
Dosage formTABLET
RouteORAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceAnastrozole
ATC codeL02BG03
AHFS class10:00.00
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02351218
DIN (unpadded, as printed on some documents)2351218
Brand nameACH-ANASTROZOLE
Generic / active ingredientANASTROZOLE : 1 MG
Market authorization holderACCORD HEALTHCARE INC
Health Canada schedulePrescription
ATC codeL02BG03
ATC anatomical main groupL — Antineoplastic and immunomodulating agents
ATC therapeutic subgroupL02BG
Current statusMARKETED
Status date23-Oct-2014
Original market date2012-10-25 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

18 of 30 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
AG-ANASTROZOLE TABLETS1 MGTABLETANGITA PHARMA INC.MARKETED02553686
ANASTROZOLE1 MGTABLETSIVEM PHARMACEUTICALS ULCMARKETED02529904
ANASTROZOLE1 MGTABLETSANIS HEALTH INCMARKETED02442736
ANASTROZOLE1 MGTABLETPRO DOC LIMITEEMARKETED02395649
APO-ANASTROZOLE1 MGTABLETAPOTEX INCMARKETED02374420
ARIMIDEX1 MGTABLETASTRAZENECA CANADA INCMARKETED02224135
BIO-ANASTROZOLE1 MGTABLETBIOMED PHARMAMARKETED02392488
JAMP ANASTROZOLE TABLETS1 MGTABLETJAMP PHARMA CORPORATIONMARKETED02540584
JAMP-ANASTROZOLE1 MGTABLETJAMP PHARMA CORPORATIONMARKETED02339080
MAR-ANASTROZOLE1 MGTABLETMARCAN PHARMACEUTICALS INCMARKETED02379562

2 · Same class — other molecules in ATC L02BG

MoleculeCanadian brandsDINsMarketedSourceable
LetrozoleACCEL-LETROZOLE TABLETS USP · ACH-LETROZOLE · AG-LETROZOLE · AG-LETROZOLE TABLETS · +31 more4018Yes
AnastrozoleACCEL-ANASTROZOLE TABLETS · ACH-ANASTROZOLE · AG-ANASTROZOLE · AG-ANASTROZOLE TABLETS · +23 more3018Yes
ExemestaneACT EXEMESTANE · APO-EXEMESTANE · AROMASIN · GD-EXEMESTANE · +3 more73Yes
AminogluthetimideCYTADREN TAB 250MG10Not in Canada
FormestaneLENTARON10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC L02B

ATC subgroupMoleculesDINsMarketed
L02BXAbiraterone · Degarelix · Relugolix2720
L02BBApalutamide · Bicalutamide · Darolutamide · Enzalutamide · Flutamide · +1 more4611
L02BAFulvestrant · Tamoxifen3610

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is ACH-ANASTROZOLE called?

The same molecule, Anastrozole, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
ARIMIDEXLatinBahrain, Czechia, Morocco
EGISTROZOLLatinCzechia
ALOZEXLatinCzechia
ANAPREXLatinCzechia
ANASTROZOL VIATRISLatinCzechia
ANASTROZOLE COOPERLatinMorocco
Anastrozole GHLatinAustralia
Anastrozole SandozLatinAustralia
ANASTROZOLE-WGRLatinAustralia
ANAYALatinCzechia
APO-AnastrozoleLatinAustralia
ATROCELALatinCzechia
Accord AnastrozoleLatinSouth Africa
ANASTROZOL MYLANLatinCzechia
ANASTROZOL TEVALatinCzechia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ACH-ANASTROZOLE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02351218. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.